Session 1.2.3

From chemical biology to therapeutic innovation


Drug discovery challenges, medicinal chemistry innovation, cancer treatment, fluorescent probes, biological system parameters.



  • KN1: Karin BRINER  (Novartis, Bâle, CH)

  • KN2: Yasuteru URANO (The University of Tokyo, JP)

  • IL1: Raphael RODRIGUEZ (Curie Institute, Paris, FR)


In this session, challenges in pharmaceutical research and medicinal chemistry's role in addressing them will be presented in different therapeutic area such as cancer or renal failure for example. The translation of fundamental chemical biology findings into therapeutic innovation will be illustrated